JP2010518070A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518070A5
JP2010518070A5 JP2009548769A JP2009548769A JP2010518070A5 JP 2010518070 A5 JP2010518070 A5 JP 2010518070A5 JP 2009548769 A JP2009548769 A JP 2009548769A JP 2009548769 A JP2009548769 A JP 2009548769A JP 2010518070 A5 JP2010518070 A5 JP 2010518070A5
Authority
JP
Japan
Prior art keywords
population
nanoparticles
group
core particles
silane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009548769A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010518070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/050084 external-priority patent/WO2008096280A1/en
Publication of JP2010518070A publication Critical patent/JP2010518070A/ja
Publication of JP2010518070A5 publication Critical patent/JP2010518070A5/ja
Pending legal-status Critical Current

Links

JP2009548769A 2007-02-07 2008-01-10 コーティングされた造影剤を使用することによる生体物質の可視化 Pending JP2010518070A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89999507P 2007-02-07 2007-02-07
PCT/IB2008/050084 WO2008096280A1 (en) 2007-02-07 2008-01-10 Visualization of biological material by the use of coated contrast agents

Publications (2)

Publication Number Publication Date
JP2010518070A JP2010518070A (ja) 2010-05-27
JP2010518070A5 true JP2010518070A5 (enExample) 2011-03-03

Family

ID=39321442

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009548769A Pending JP2010518070A (ja) 2007-02-07 2008-01-10 コーティングされた造影剤を使用することによる生体物質の可視化

Country Status (8)

Country Link
US (2) US20100111859A1 (enExample)
EP (2) EP2121040A1 (enExample)
JP (1) JP2010518070A (enExample)
CN (1) CN101663050A (enExample)
AU (1) AU2008212556A1 (enExample)
CA (1) CA2675631A1 (enExample)
WO (2) WO2008096279A1 (enExample)
ZA (1) ZA200905420B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2943712C (en) 2007-07-30 2019-06-04 The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Northern Arizona University Methods and devices for the detection of biofilm
JP2010537971A (ja) * 2007-08-31 2010-12-09 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 磁粉イメージング用トレーサとしての集団磁粉
CA2735649C (en) * 2008-09-02 2018-03-27 University Of Maryland, Baltimore In vivo biofilm infection diagnosis and treatment
US8574549B2 (en) * 2008-12-29 2013-11-05 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
WO2011123030A1 (en) * 2010-03-30 2011-10-06 Spago Imaging Ab Nanoparticles comprising a core of amorphous rare earth element hydroxide and an organic coating
BR112013000907A2 (pt) * 2010-07-16 2017-10-31 Univ Denmark Tech Dtu composição, partícula nanodimensionada para uso em registro de imagem de raios-x e método para tratamento de uma condição ou doença associada ao crescimento indesejável de células em um indivíduo com necessidade dele
EP2649135A1 (en) * 2010-12-08 2013-10-16 Dow Corning Toray Co., Ltd. Methods of modifying metal-oxide nanoparticles
US9474810B2 (en) 2012-03-02 2016-10-25 General Electric Company Superparamagnetic nanoparticles with PEG substituted α-hydroxy phosphonate shells
WO2014107055A1 (ko) * 2013-01-04 2014-07-10 연세대학교 산학협력단 나노입자 지지체 표면에 코팅된 t1 조영물질을 포함하는 mri 조영제
EP2923712A1 (en) * 2014-03-28 2015-09-30 Spago Imaging AB Nanostructures and applications thereof
CN104021411B (zh) * 2014-05-30 2017-11-24 江苏多维科技有限公司 一种磁防伪标识及其识别系统
CA2961358C (en) * 2014-09-15 2023-08-01 Massachusetts Institute Of Technology Nanoparticles for magnetic resonance imaging applications
WO2018154165A1 (es) * 2017-02-21 2018-08-30 Fundación Pública Andaluza Progreso Y Salud Nanopartículas modificadas con derivados alcoxi-silanos
JP2023509954A (ja) 2020-01-14 2023-03-10 セインベルグ、リイス 金属系コアナノ粒子、合成および使用
KR102379752B1 (ko) * 2020-08-19 2022-03-28 국민대학교산학협력단 X-선 감쇠 기반 생체 이미징용 나노입자 및 조성물
CN112485283B (zh) * 2020-11-20 2024-05-17 中国农业科学院农产品加工研究所 基于细胞膜完整性变化的干燥技术评价方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
DE19612001A1 (de) 1996-03-18 1997-09-25 Silica Gel Gmbh Adsorptions Te Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung
IL157576A0 (en) * 2001-03-08 2004-03-28 Nanosolutions Gmbh Paramagnetic nanoparticle
CN1231760C (zh) 2001-03-30 2005-12-14 清华大学 用于生物材料标记的稀土纳米粒子、其制备方法及用途
WO2003080743A2 (en) * 2002-03-19 2003-10-02 The Regents Of The University Of California Stabilized inorganic particles
FR2867180B1 (fr) 2004-03-02 2006-06-16 Univ Claude Bernard Lyon Nanoparticules hybrides comprenant un coeur de ln203 porteuses de ligands biologiques et leur procede de preparation
US20060014938A1 (en) * 2004-07-14 2006-01-19 Groman Ernest V Stable aqueous colloidal lanthanide oxides
JP2008513053A (ja) 2004-09-14 2008-05-01 オプトクリツト・アー・ベー 超常磁性ガドリニウム酸化物ナノスケール粒子およびそのような粒子を含む組成物
US7462446B2 (en) * 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods

Similar Documents

Publication Publication Date Title
JP2010518070A5 (enExample)
AU2009334868B2 (en) Nanoparticle contrast agents for diagnostic imaging
Kamimura et al. Near-infrared (1550 nm) in vivo bioimaging based on rare-earth doped ceramic nanophosphors modified with PEG-b-poly (4-vinylbenzylphosphonate)
Hirn et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration
US8734762B2 (en) Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same
US8728529B2 (en) Nanoparticle contrast agents for diagnostic imaging
Zhang et al. PolyPEGylated nanodiamond for intracellular delivery of a chemotherapeutic drug
Guo et al. Color-tunable Gd-Zn-Cu-In-S/ZnS quantum dots for dual modality magnetic resonance and fluorescence imaging
US9399075B2 (en) Nanoparticle contrast agents for diagnostic imaging
JP2010518070A (ja) コーティングされた造影剤を使用することによる生体物質の可視化
Ahmad et al. Functionalized lanthanide oxide nanoparticles for tumor targeting, medical imaging, and therapy
US20100166664A1 (en) Nanoparticle contrast agents for diagnostic imaging
Galloway et al. Quantitative characterization of the lipid encapsulation of quantum dots for biomedical applications
Kim et al. Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications
US8574549B2 (en) Nanoparticle contrast agents for diagnostic imaging
Rutledge et al. Thiol− ene induced diphosphonic acid functionalization of superparamagnetic iron oxide nanoparticles
Cui et al. Al (OH) 3 facilitated synthesis of water-soluble, magnetic, radiolabelled and fluorescent hydroxyapatite nanoparticles
JP2014001159A (ja) 薬物を担持した表面修飾酸化鉄ナノ粒子
Mai et al. Anionic polymer brushes for biomimetic calcium phosphate mineralization—a surface with application potential in biomaterials
Saville et al. Investigation of the stability of magnetite nanoparticles functionalized with catechol based ligands in biological media
Liu et al. Enhanced tumor imaging using glucosamine-conjugated polyacrylic acid-coated ultrasmall gadolinium oxide nanoparticles in magnetic resonance imaging
Heng et al. Comparative cytotoxicity evaluation of lanthanide nanomaterials on mouse and human cell lines with metabolic and DNA-quantification assays
Novy et al. Head-To-head comparison of biological behavior of biocompatible polymers poly (ethylene oxide), poly (2-ethyl-2-oxazoline) and poly [N-(2-hydroxypropyl) methacrylamide] as coating materials for hydroxyapatite nanoparticles in animal solid tumor model
US20100278748A1 (en) Nanoparticle contrast agents for diagnostic imaging
US20140093550A1 (en) Nanoparticle - Biocide Treatment of Biofilms